Business Trends

Sep 15, 2017
BioPharm International
Cell-based therapies are moving medical treatments forward, but intellectual property uncertainties may delay progress.
Sep 01, 2017
BioPharm International
Faced with divisive political and social issues, Congress must find a way to reach consensus.
Jul 01, 2017
BioPharm International
How has the bio/pharmaceutical contract manufacturing industry evolved and changed over the years and what does the future hold?
Jul 01, 2017
BioPharm International
CDER’s Janet Woodcock endorses modern drug manufacturing to ensure access to safe and reliable medicines.
Jul 01, 2017
BioPharm International
New reports address biopharma’s leading concerns: funding for drug development and pricing of finished drugs.
Jun 27, 2017
By BioPharm International Editors
Drug sales forecasts fall for first time in 10 years, thanks to pressures to reduce drug prices and the advent of biosimilars.
Jun 27, 2017
By BioPharm International Editors
BIO report measures decade-long investment and acquisition trends for emerging biotech companies.
Jun 01, 2017
BioPharm International
New reports indicate that drug prices are slowing compared to other healthcare costs.
May 24, 2017
By BioPharm International Editors
In Lazard's Global Healthcare Leaders 2017 survey, most respondents said pricing and reimbursement were the most significant challenge, but nearly half of the pharma executives who responded see value-based pricing as having the greatest impact on the business, potentially even more than scientific breakthroughs.
May 24, 2017
By BioPharm International Editors
The 2017 Global Healthcare Leaders Survey suggests that value-based and risk-sharing payment could have an even more transformative impact on the industry than scientific breakthroughs.
native1_300x100
lorem ipsum